Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Kevin A. Scott, Jon T. Njardarson
Index: 10.1007/s41061-018-0184-5
Full Text: HTML
Abstract
In this review, we discuss all sulfur-containing FDA-approved drugs and their structures. The second section of the review is dedicated to structural analysis and is divided into 14 subsections, each focusing on one type of sulfur-containing moiety. A concise graphical representation of each class features drugs that are organized on the basis of structural similarity, evolutionary relevance, and medical indication. This review offers a unique and comprehensive overview of the structural features of all sulfur-containing FDA-approved drugs to date.
Latest Articles:
Towards Synergistic Electrode–Electrolyte Design Principles for Nonaqueous Li–O $$_2$$ 2 batteries
2018-03-20
[10.1007/s41061-018-0188-1]
Quinodimethanes Incorporated in Non-Benzenoid Aromatic or Antiaromatic Frameworks
2018-03-20
[10.1007/s41061-018-0189-0]
Electronic Couplings in (Bio-) Chemical Processes
2018-03-20
[10.1007/s41061-017-0180-1]
Electrochemical Synthesis of Battery Electrode Materials from Ionic Liquids
2018-02-21
[10.1007/s41061-018-0186-3]
Chemical Valorization of Cashew Nut Shell Waste
2018-02-13
[10.1007/s41061-017-0177-9]